Welcome to LookChem.com Sign In|Join Free
  • or
Phosphoramidous acid, bis(1-methylethyl)-, 2-cyanoethyl 19,19-bis(4-methoxyphenyl)-19-phenyl-3,6,9,12,15,18-hexaoxanonade c-1-yl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

125607-09-2

Post Buying Request

125607-09-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

125607-09-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 125607-09-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,5,6,0 and 7 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 125607-09:
(8*1)+(7*2)+(6*5)+(5*6)+(4*0)+(3*7)+(2*0)+(1*9)=112
112 % 10 = 2
So 125607-09-2 is a valid CAS Registry Number.

125607-09-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-O-DMT-6-β-cyanoethyl-N,N-diisopropylphosphoramidite-hexaethylene glycol

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:125607-09-2 SDS

125607-09-2Downstream Products

125607-09-2Relevant academic research and scientific papers

A SYSTEM FOR DELIVERING THERAPEUTIC AGENTS INTO LIVING CELLS AND CELL NUCLEI

-

Page/Page column 90-91, (2008/06/13)

A novel class of oligomeric compounds designed for forming conjugates with biologically active substances and delivering these substances to a desired bodily target are disclosed. Nove1 conjugates of biologically active moities and such oligomeric compounds, pharmaceutical compositions containing such conjugates, and uses thereof as delivery systems for delivering the biologically active substances to a desired target are further disclosed. Processes of preparing the conjugates and the oligomeric compounds and novel intermediates designed for and used in these processes are also disclosed.

Binding of aminoglycoside antibiotics with modified A-site 16S rRNA construct containing non-nucleotide linkers

Tok, Jeffrey B.-H.,Wong, Wilson,Baboolal, Nyla

, p. 365 - 370 (2007/10/03)

The design and synthesis of synthetically modified cyclic A-site 16S rRNA construct is reported. The binding characteristics of several members of the aminoglycoside antibiotics with this novel class of synthetically modified A-site 16S rRNA constructs we

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 125607-09-2